SP7 and breast carcinoma: Previous research that investigated osterix expression in 154 tumours from breast cancer patients demonstrated that high expression was associated with an unfavourable survival outcome and the presence of lymph node metastasis [10]; however, a later study examining 112 breast tumours did not show any significant associations with any available clinicopathological criteria.